Skip to main content

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investor Securities Class Action Lawsuit 09/26/2018

  • If you purchased shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 23, 2020 - TThe court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. July 31, 2019 - A motion to dismiss the amended complaint was filed. July 3, 2019 - An amended complaint was filed. September 26, 2018 - An investor in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) filed a lawsuit in the U.S. District Court for the So...



You must register (for free) or login to view the entire case.